Jia-wei Xin
Fujian Medical University Union Hospital, Fujian Key Laboratory Of Molecular Neurology And Institute Of Neuroscience
Fuzhou, China
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.
Journal: Brain : a journal of neurology
Published: January 26, 2026
Plasma p-Tau217 improves diagnostic accuracy and clinician confidence in cognitive disorder classification.
Journal: Innovation (Cambridge (Mass.))
Published: October 10, 2025
Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.
Journal: Brain : a journal of neurology
Published: August 14, 2025
Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.
Journal: Brain : a journal of neurology
Published: August 14, 2025
Role of 18F-florzolotau PET in diagnostic and therapeutic decision-making for cognitive impairment.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 06, 2025
Clinical utility of cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic workup of complex patients with cognitive impairment.
Journal: Translational psychiatry
Published: September 30, 2024
Abnormal resting-state functional connectivity in posterior cingulate cortex of Parkinson's disease with mild cognitive impairment and dementia.
Journal: CNS neuroscience & therapeutics
Published: November 12, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026